Xwell (XWEL) Total Debt Growth (1y) (2011 - 2024)
Xwell (XWEL) Total Debt Growth (1y) (2011 - 2024) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 48.73% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -20.41% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -4.01% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 3.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -72.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -0.07% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -3.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -0.37% |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 109.35% |
| Mar 31, 2024 | -5.57% |
| Dec 31, 2023 | -53.37% |
| Sep 30, 2023 | -46.86% |
| Jun 30, 2023 | -46.86% |
| Mar 31, 2023 | -68.67% |
| Dec 31, 2022 | -78.26% |
| Sep 30, 2022 | -92.53% |
| Jun 30, 2022 | -89.03% |
| Mar 31, 2022 | -74.65% |
| Dec 31, 2021 | -21.65% |
| Sep 30, 2021 | 34.39% |
| Jun 30, 2021 | 13.21% |
| Mar 31, 2021 | 58.70% |
| Dec 31, 2020 | -25.24% |
| Sep 30, 2020 | 102.58% |
| Jun 30, 2020 | 4.72% |
| Mar 31, 2020 | -45.20% |
| Dec 31, 2019 | 16.34% |
| Sep 30, 2019 | -36.11% |